Journal
BRITISH JOURNAL OF CANCER
Volume 123, Issue 2, Pages 240-251Publisher
SPRINGERNATURE
DOI: 10.1038/s41416-020-0887-6
Keywords
-
Categories
Funding
- Cancer Research Society
- Leukemia and Lymphoma Society of Canada
- Canadian Institutes of Health Research (CIHR) [FRN-152986, FRN-408093]
- Canada Research Chair Program
- Fonds de Recherche du Quebec-Sante (FRQS)
- Universite Laval foundation-Leadership and sustainable development award
- CHU de Quebec foundation-Fernand Labrie excellence award
- FRQS
Ask authors/readers for more resources
Background High UGT2B17 is associated with poor prognosis in untreated chronic lymphocytic leukaemia (CLL) patients and its expression is induced in non-responders to fludarabine-containing regimens. We examined whether UGT2B17, the predominant lymphoid glucuronosyltransferase, affects leukaemic drug response and is involved in the metabolic inactivation of anti-leukaemic agents. Methods Functional enzymatic assays and patients' plasma samples were analysed by mass-spectrometry to evaluate drug inactivation by UGT2B17. Cytotoxicity assays and RNA sequencing were used to assess drug response and transcriptome changes associated with high UGT2B17 levels. Results High UGT2B17 in B-cell models led to reduced sensitivity to fludarabine, ibrutinib and idelalisib. UGT2B17 expression in leukaemic cells involved a non-canonical promoter and was induced by short-term treatment with these anti-leukaemics. Glucuronides of both fludarabine and ibrutinib were detected in CLL patients on respective treatment, however UGT2B17 conjugated fludarabine but not ibrutinib. AMP-activated protein kinase emerges as a pathway associated with high UGT2B17 in fludarabine-treated patients and drug-treated cell models. The expression changes linked to UGT2B17 exposed nuclear factor kappa B as a key regulatory hub. Conclusions Data imply that UGT2B17 represents a mechanism altering drug response in CLL through direct inactivation but would also involve additional mechanisms for drugs not inactivated by UGT2B17.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available